Section I: Pharmacologic Intervention 1. Role of Platelet - Inhibitor Agents in Coronary Artery Disease 2. Anticoagulants and Their Use in Acute Coronary Syndromes and Coronary Interventions 3. Effects of Beta - Blockers, Calcium Channel Blockers, Nitrates, and Magnesium in Acute Myocardial Infarction and Unstable Angina Pectoris 4. Angiotensin - Converting Enzyme Inhibition and Angiotensin Receptor Blockers and Extended on 5. Thrombolytic Intervention 6. Hypolipidemic Intervention and Prospects for Regression Section II: Coronary and Peripheral Intervention: Key Applications 7. Percutaneous Coronary and Peripheral Intervention: Historical Perspective 8. Elective Coronary Intervention: Indications, Technique and Complications 9. Percutaneous Coronary Intervention for Unstable angina 10. Complex Intervention 11. Efficacy of Percutaneous Coronary Intervention 12. Peri - Procedural Myocardial Infarction and Emboli Protection 13. Abrupt Vessel Closure 14. Catheter - Based Reperfusion for acute Myocardial Infarction 15. Chronic Total Occlusion 16. Percutaneous Intervention in Patients with Prior Coronary Bypass Surgery 17. Ostial and bifurcation lesions 18. Long Lesions and Diffuse Disease 19. Inflammation and Arterial Injury 20. Animal Models of Human Coronary Restenosis 21. Restenosis: The Clinical Issues 22. Approach to Restotic Lesions 23. Surgical Standby for Percutaneous Intervention 24. Interventional Vascular Procedures in the Peripheral, renal, Visceral and Extracranial Circulation 25. Coronary Atherectomy: Directional and Extraction Techniques 26. Rotoblation 27. Stents: Technique and Adjunctive Therapy 28. Stents: The Menu 29. Stents: Indications and Limitations 30. Coated Stents and Local Drug Delivery for the Prevention of Restenosis 31. Laser 32. Ultrasound Angioplasty 33. Radiation for Restenosis 34. Percutaneous Myocardial Revascularization 35. Angiogenesis 36. Percutaneous Bypass Surgery 37. Percutaneous Vascular Hemostatis Devices for Arterial Sealing after Interventional Procedures Section III: Bacterial, Protozoal and Arthropod Infections 38. Interventional Approaches to the Introduction of Genetic Material into the Cardiovascular System 39. Qualitative and Quantitative Angiography 40. Intracoronary Doppler and Pressure Monitoring 41. Percutaneous Coronary Angioscopy 42. Intravascular Ultrasound Section IV: Valvuloplasty, Congenital and Pericardial Heart Disease 43. Mitral Valvuloplasty 44. Advances in Percutaneous Aortic and Mitral Valvuloplasty 45. Congenital Heart Disease 46. Percutaneous Balloon Percardiotomy for Patients with Pericardial, Effusion and Tamponade 47. Catheter Based Treatment for Patients with Hypertrophic Obstructive Section V: Outcome Effectiveness of Interventional Cardiology 48. Medical Economics and Interventional Cardiology 49. Quality of Care in Interventional Cardiology 50. Training, Credentialing and Guidelines Section VI: Emerging Technologies 51. Device Genomics 52. Stem Cell Therapy for Ischemic Heart Disease 53. Detection of Vulnerable Plaque
